Orthofeet, Inc. ("Orthofeet"), a leading designer and manufacturer of biomechanically designed footwear, announced the launch of its first direct-to-consumer website – www.orthofeet.com. The new website, a re-design of its existing health care provider website, offers a convenient, secure way to browse and purchase a wide variety of therapeutic shoes for men and women. The site also features educational resources about foot care, with customized content for adults with diabetes who are prone to medical foot conditions.
Mephisto launches its Nature is Future collection worldwide. At the latest edition of Micam, held from Sept. 18 to 20 in Milan for the presentation of spring/summer 2023 collections, Mephisto started distributing worldwide its sustainable women and men’s sneakers brand Nature is Future by Mephisto.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 2508
Published Date: Jul 21, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The major driving growth factor for this market is the increasing population with chronic diseases.
The market size of Orthopedic Footwear market is anticipated to attain a CAGR of 10% over the forecast period, i.e., 2023 – 2035.
The major players in the market are Dr. Comfort, Mephisto, Apex, Propet, Vionic, Chaneco, Duna, Orthofeet Inc., Piedro, and others.
The shoes segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.